Table 5 Summary of multivariable regression model for respiratory complications
Term | Estimated coefficient | 95% CI lower | 95% CI upper | Estimated odds ratio | P value |
|---|---|---|---|---|---|
Intercept | −1.33 | −2.70 | 0.02 | 0.26 | - |
Postoperative buprenorphine continuation (yes vs. no) | −0.83 | −1.60 | −0.15 | 0.43 | 0.02 |
Surgery category | |||||
Musculoskeletal (vs. digestive) | −1.19 | −2.04 | −0.31 | 0.31 | 0.007 |
Integumental (vs. digestive) | −0.87 | −2.00 | 0.19 | 0.42 | 0.11 |
Other (vs. digestive) | −0.37 | −1.29 | 0.55 | 0.69 | 0.42 |
Regional anesthesia (yes vs. no) | −0.50 | −1.54 | 0.39 | 0.61 | 0.31 |
BMI, kg/m2 | 0.03 | −0.01 | 0.07 | 1.03 | 0.11 |
Indication for buprenorphine (Chronic pain vs. opioid use disorder) | −0.45 | −1.28 | 0.30 | 0.64 | 0.26 |
Preoperative buprenorphine dose (≥16mg vs. < 16 mg) | −0.10 | −0.76 | 0.55 | 0.90 | 0.76 |